News
Circle Pharma to Present Late-Breaking Data at AACR 2025 Demonstrating Mechanism of Action for Novel Cyclin A/B RxL Inhibitors Circle Pharma, a clinical-stage biopharmaceutical company focused on ...
John L. Marshall, MD, discusses the sequencing of targeted therapy for refractory metastatic colorectal cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback